Milestone Taking Etripamil Into Phase III For AFib Based On Phase II Success

Approval For PSVT Pending At The US FDA

 
• By Mandy Jackson
  
Atrial fibrillation medical condition and normal or abnormal heart rate rhythm as a cardiac disorder
Etripamil rapidly slowed ventricular rates in atrial fibrillation patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D